Technetium-99m pyridoxylideneglutamate (P.G.) cholescintigraphy.
Technetium-99m P.G. cholescintigraphy was performed in 27 human volunteers and 81 patients referred for hepatobiliary tract disease. The gallbladder, biliary system, and gastrointestinal tract were well visualized in the normal patients and volunteers. The gallbladder was not visualized in 22 patients with histologically proved cholecystitis with cystic duct obstruction. Nine patients with complet extrahepatic obstruction of the common bile duct were correctly diagnosed. Hepatocellular disease and incomplete obstruction, with and without jaundice, were diagnosed with this technique. Oral cholecystography is superior to this method for the detection of cholelithiasis in nonjaundiced patients.
D001660:Biliary Tract Diseases / Q000175:diagnosis*; D002764:Cholecystitis / Q000175:diagnosis; D002769:Cholelithiasis / Q000175:diagnosis; D002779:Cholestasis / Q000175:diagnosis; D005705:Gallbladder Diseases / Q000175:diagnosis; D006801:Humans; D007565:Jaundice / Q000175:diagnosis / Q000209:etiology; D008107:Liver Diseases / Q000150:complications / Q000175:diagnosis*; D011730:Pyridoxal / Q000031:analogs & derivatives*; D011877:Radionuclide Imaging; D013667:Technetium
D011730:Pyridoxal; D013667:Technetium